StonvexLoading…
StonvexStonvexStonvexCore line items from GDYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $108.72M | $104.10M | $411.83M | $305.67M | $201.51M |
Operating Income | Not available | $-3.68M | $-1.90M | $-2.40M | $-2.16M |
Net Income | Not available | $-1.47M | $9.67M | $9.36M | $5.27M |
EPS (Diluted) | $0.11 | $-0.02 | $0.11 | $0.11 | $0.09 |
Total Assets | Not available | $605.02M | $612.89M | $613.17M | $608.91M |
Total Liabilities | Not available | $74.90M | $70.82M | $75.45M | $76.69M |
Cash & Equivalents | Not available | $327.47M | $342.06M | $338.55M | $336.75M |
Free Cash Flow OCF − CapEx | Not available | $4.43M | $25.27M | $19.17M | $16.22M |
Shares Outstanding | Not available | 83.57M | 84.64M | 84.71M | 84.61M |